Language:
eu
es
en
Basque Research Elhuyar - Zientzia

BASQUE RESEARCH
 Basque research, development and innovation web site

Contact:
Laura Juampérez
Universidad de Navarra
Contact details:
ljuamperez@unav.es
(+34) 948 425600 ext. 6620
Universidad de Navarra

2009/5/20

New strategies for cell therapy to regenerate damaged heart

Research undertaken at the Center for Applied Medical Research (CIMA) and the University Hospital of Navarra has shown that, in animal models, stem cells derived from bone marrow and adipose tissue enhance heart function after a cardiac attack. In concrete, bone marrow cells act on the damaged tissue, while fatty cells have the ability to transform themselves into both blood vessels and cardiac cells. The results obtained with rats are maintained over a long time period, explained biochemist Mr Manuel Mazo, principal researcher.

When a person suffers a heart attack, the artery feeding the heart is obstructed The affected tissue dies and the scar tissue left des not contract. It is a serious problem as cardiac muscle does not regenerate, with grave consequences for the functional capacity of the heart, a situation which can trigger heart failure, explained the scientist.

Mortality for cardiovascular diseases

Myocardial arrest is a pathology which has one of the highest rates worldwide. In fact, the overall number of cardiovascular illnesses represents 50% of deaths in Europe, according to the world Health Organisation.

For a decade now they have been investigating new strategies of genic therapy and cell therapy that enable the repopulation of the scar tissue in the heart in order to regenerate it. In the opinion of Dr. Manuel Mazo, the data obtained at CIMA suggest that this procedure has a highly important potential in its clinical application. This is why the effects which are being achieved have to be improved in both animal models as well as in other, multicentre clinical trials. In this way, the future of the research is focused on combining cell therapy and bioengineering, in such a way that genetically modified cells surviving from adverse conditions in the heart are available.

Medikuntza, Bioteknologia Go to top of page
Additional information
Documents
Go to top of page

Search

Search in Basque Research [ Advanced search ]

Login

Users data

Navigation

Main menu

Go to top of page

Thesis Prize and International network

Go to top of page Go to top of page

Statistics

Go to top of page

XML RSS Feeds

Go to top of page

Standars and accesibility

Go to top of page

Register

Go to top of page

Menu for registered users

Go to top of page


BR Eraberritzen Bloga


Services

Go to top of page Go to top of page

Sponsors:

Eusko Jaurlaritza

The use of the contents of this website is forbidden without permission.

Copyright © 2007 Elhuyar Fundazioa

basqueresearch@elhuyar.com